Literature DB >> 28651851

Meta-Analysis of Cardiovascular Outcomes With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea.

Ahmed S Abuzaid1, Haitham S Al Ashry2, Ayman Elbadawi3, Ha Ld3, Marwan Saad4, Islam Y Elgendy5, Akram Elgendy5, Ahmed N Mahmoud5, Amgad Mentias6, Amr Barakat7, Chitra Lal8.   

Abstract

Obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity and mortality. Continuous positive airway pressure (CPAP) is the main treatment of OSA. The present study explores the impact of CPAP on cardiovascular outcomes. A systematic search of electronic databases for randomized controlled trials comparing CPAP with medical therapy alone in patients with OSA who reported cardiovascular outcomes of interest was performed. The main outcome was major adverse cardiac events. Other outcomes included cardiac mortality, myocardial infarction, angina pectoris, stroke, and transient ischemic attack. Fixed effect model was used in all analyses except for subgroup analysis in which the random effect DerSimonian and Laird's model was used. Four randomized controlled trials with a total of 3,780 patients were included. Compared with medical therapy alone, CPAP use was not associated with reduced risk of major adverse cardiac events (relative risk [RR] 0.94, 95% confidence interval [CI] 0.78 to 1.15, p = 0.93, I2 = 0%) except in the subgroup that wore CPAP >4 hours (RR 0.70, 95% CI 0.52 to 0.94, p = 0.02, I2 = 0%). Furthermore, no reduction in the risk of cardiac mortality (RR 1.14, 95% CI 0.66 to 1.97, p <0.36, I2 = 2%), myocardial infarction (RR 0.96, 95% CI 0.64 to 1.44, p <0.15, I2 = 47%), angina pectoris (RR 1.16, 95% CI 0.9 to 1.50, p <0.51, I2 = 0%), stroke (RR 1.01, 95% CI 0.73 to 1.38, p <0.0.86, I2 = 0%), and transient ischemic attack (RR 1.36, 95% CI 00.69 to 2.68, p <0.24, I2 = 30%) was observed. Subgroup analysis of CPAP adherence in regards to cardiac outcomes showed that CPAP use is not associated with decreased risk of heart failure (RR 0.91, 95% CI 0.50 to 1.66, p <0.55, I2 = 0%). In conclusion, compared with medical therapy alone, utilization of CPAP in patients with OSA is not associated with improved cardiac outcomes except in patients who wore it for >4 hours.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28651851     DOI: 10.1016/j.amjcard.2017.05.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  33 in total

1.  Metoprolol has a similar therapeutic effect as amlodipine on BP lowering in hypertensive patients with obstructive sleep apnea.

Authors:  Jing Shi; Yue Yuan; Xianzhu Deng; Yujiao Pan; Meijiao He; Guangzhong Liu; Danghui Sun; Jiayu Wang; Wennan Wang; Yue Li
Journal:  Sleep Breath       Date:  2018-06-27       Impact factor: 2.816

Review 2.  A Clinical Perspective of Sleep and Andrological Health: Assessment, Treatment Considerations, and Future Research.

Authors:  Peter Y Liu
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

3.  Continuous positive airway pressure.

Authors:  Peter Ran Yang; Christina Korownyk
Journal:  Can Fam Physician       Date:  2018-10       Impact factor: 3.275

Review 4.  Cardiovascular outcomes of continuous positive airway pressure therapy for obstructive sleep apnea.

Authors:  Yüksel Peker; Baran Balcan
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

5.  Obstructive Sleep Apnea in Children and Adolescents and the Risk of Major Adverse Cardiovascular Events: A Nationwide Cohort Study in Taiwan.

Authors:  Nian-Sheng Tzeng; Chi-Hsiang Chung; Hsin-An Chang; Chuan-Chia Chang; Ru-Band Lu; Hui-Wen Yeh; Wei-Shan Chiang; Yu-Chen Kao; Shan-Yueh Chang; Wu-Chien Chien
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

Review 6.  Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.

Authors:  Islam Y Elgendy; Dhruv Mahtta; Carl J Pepine
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

7.  Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: from the compliance to adaptation, maladaptation and reflexes.

Authors:  Carolina Lombardi; Sergio Caravita; Gianfranco Parati
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 8.  A review of the associations between obstructive sleep apnea and hypertensive disorders of pregnancy and possible mechanisms of disease.

Authors:  Jennifer E Dominguez; Ashraf S Habib; Andrew D Krystal
Journal:  Sleep Med Rev       Date:  2018-05-28       Impact factor: 11.609

Review 9.  Cardiorespiratory interaction with continuous positive airway pressure.

Authors:  Martino F Pengo; Sara Bonafini; Cristiano Fava; Joerg Steier
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

10.  CPAP Therapy Delays Cardiovagal Reactivation and Decreases Arterial Renin-Angiotensin System Activity in Humans With Obstructive Sleep Apnea.

Authors:  David D M Nicholl; Patrick J Hanly; Ann A Zalucky; Michelle C Mann; Jennifer M MacRae; Marc J Poulin; George B Handley; Darlene Y Sola; Sofia B Ahmed
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.